Ensysce Biosciences Inc

NASDAQ:ENSC 3:57:59 PM EDT

0.56

+0.02 (+3.20%)

5:01:02 PM EDT: $0.55 -0.01 (-0.97%)

Market Cap (Intraday)	1.76M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.4 Million
Adjusted EPS	-$0.90

See more estimates

10-Day MA	$0.63
50-Day MA	$0.80
200-Day MA	$1.27

See more pivots

Ensysce Biosciences Inc Stock, NASDAQ:ENSC

7946 Ivanhoe Avenue, Suite 201, La Jolla, California 92037

United States of America

Phone: +1.858.263.4196

Number of Employees:

http://www.ensysce.com

Description

Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of solutions for severe pain relief while reducing the fear of and the potential for misuse and overdose. The firm's Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms are in the process of developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. The company was founded in April 2003 and is headquartered in La Jolla, CA.